Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
BioNTech SE
Travera Inc
Turning Point Therapeutics, Inc.
Hoffmann-La Roche
Cancer Research UK
Hoffmann-La Roche
Karolinska University Hospital
Eli Lilly and Company
Tanabe Pharma America, Inc.
Cancer Research UK
Massive Bio, Inc.
Day One Biopharmaceuticals, Inc.
Vyriad, Inc.
Société Algérienne de Formation et de Recherche en Oncologie
JS InnoPharm, LLC
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
EpicentRx, Inc.
Eli Lilly and Company
Purple Biotech Ltd.
Aminex Therapeutics, Inc.
Travera Inc
Rain Oncology Inc
Mayo Clinic
Fudan University
Boston Pharmaceuticals
National Cancer Institute (NCI)
Institut Bergonié
Xencor, Inc.
M.D. Anderson Cancer Center
Novartis
Infinity Pharmaceuticals, Inc.
EMD Serono
Amgen
Fore Biotherapeutics
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Eli Lilly and Company
SWOG Cancer Research Network
University of Southern California
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)